Share Name Share Symbol Market Type Share ISIN Share Description
Healthcare Inv LSE:HIO London Ordinary Share GB00B94T6Y14 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 14.75p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial - - - - 5.95

Healthcare Inv Share Discussion Threads

Showing 26 to 49 of 50 messages
Chat Pages: 2  1
DateSubjectAuthorDiscuss
05/1/2014
15:53
HIO now moved to COS
cnx
02/1/2014
15:46
Sorry I can't Mirabeau as I'm not a subscriber! I've set up a new thread on M----am. :-)
doodlebug4
02/1/2014
14:22
Set one up ffs!
mirabeau
02/1/2014
14:21
No new thread as yet, latifs. The new epic is COS.
doodlebug4
02/1/2014
12:13
this is now called collagen solutions. is here a new thread?
latifs100
30/12/2013
14:29
From an article in the Daily Mail published 31st July. Flotation was in April. "At the time of HIO's flotation Evans was granted options over 4.05million shares (10 per cent of the equity), which will only vest in the event that an acquisition is completed within 12 months from admission, and if the share price is in excess of 20p per share. Once vested, the exercise period of the options will be 10 years and the exercise price will be 10p per share. Evans has a big City fan club and it is easy to see why. The companies under his stewardship have a strong record of value generation for shareholders. He was chief executive of Shield Diagnostics prior to the merger with Axis Biochemicals to form Axis Shield in 1999. He was also chairman of Immunodiagnostic Systems, which floated in December 2004 at 51p and was trading at 1046p at the time he left the company in September 2011."
doodlebug4
27/12/2013
15:32
Director Shareholding RNS RNS Number : 4668W Healthcare Investment Opportunities 27 December 2013 27 December 2013 Healthcare Investment Opportunities Plc (the "Company") Director Shareholding Healthcare Investment Opportunities plc (AIM: HIO), an investment company focusing on the healthcare sector, announces that today Malcolm Gillies, a Director of Healthcare Investment Opportunities, has purchased a total of 250,000 ordinary shares at an average price of 12.789 pence per share. This brings Malcolm Gillies' interest in the Company's current issued share capital to 500,000 being 1.24% of the current issued share capital.
doodlebug4
13/12/2013
12:40
David Evans has a pretty impressive track record. Nice little delayed trade just gone through.
doodlebug4
11/12/2013
08:36
rivaldo, tend to agree with you. Will carry on watching from the sidelines.
127tolmers
10/12/2013
15:59
Been following this one for a while without buying, but I must say I find today's acquisition most uninspiring/disappointing. Quite happy to be put right, but it seems the market agrees with me so far.
rivaldo
29/11/2013
06:02
It is well past the six months timescale predicted in the prospectus ,perhaps we will hear soon some news
wingrove4
26/11/2013
15:48
Something stirring here at last?
doodlebug4
17/10/2013
15:06
I am a little frustrated no news and well past 6 months. Still they say no news is good news
4wingrove
06/9/2013
08:30
Nice tick up again this morning.
doodlebug4
06/9/2013
08:28
Further tick up this morning, and looking like is all buys
master rsi
05/9/2013
18:56
Large late buy at 15. Presumably these swings follow potential investments brewing and then fading. Something probably brewing
ade45
05/9/2013
14:12
Admitted to AIM on 10th April so the clock is ticking now and not long left until the six months is up. "The Board, through its extensive network of contacts, has identified a number of potentially interesting investment opportunities, although formal discussions in respect of any of these opportunities have not yet commenced. The Board anticipates the first acquisition will be a reverse takeover, in accordance with the AIM Rules for Companies, will be subject to prior shareholder approval and the publication of an admission Document and is expected to be made within 6 months of Admission. In addition, the Board may also consider making other smaller acquisitions or investments although the Directors do not intend to create a portfolio of unconnected companies."
doodlebug4
05/9/2013
14:09
Something's beginning to bubble here, I agree Master RSI.
doodlebug4
05/9/2013
14:06
Bouncing after retracement, some large buys for the last couple days and Market Makers looking like short of stock
master rsi
31/7/2013
16:02
Delayed trades put through this afternoon, I suppose some of the people who bought in at the original float price in April might be happy to cash in on their profit. I'm happy to wait this one out, even if it takes 7 years for David Evans to put in a similar performance to the one when he was chairman of Immundiagnostic Systems !
doodlebug4
31/7/2013
14:09
Buyers paying the full offer price of 17p now.
doodlebug4
31/7/2013
12:22
Evans is a respected figure in the City. His credentials are impeccable but this stock's speculative but if anyone's got the expertise and experience to succeed then Evans surely has
mirabeau
31/7/2013
12:18
I like the last sentence of that article in the Daily Mail - referring to David Evans. He's certainly got a good CV ! "He was also chairman of Immunodiagnostic Systems, which floated in December 2004 at 51p and was trading at 1046p at the time he left the company in September 2011."
doodlebug4
31/7/2013
11:18
I've just bought a few tpinvest, whether or not the hot gossip turns out to be accurate it would appear that David Evans has a good track record - so this is worth a punt imo.
doodlebug4
Chat Pages: 2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161209 19:26:34